Methods of modulating β cell function

Details Methods of modulating β cell function Methods of modulating β cell function

2007-08-14

2007-08-14

Tsang, Ceclilia J. (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S003100, C530S333000, C530S333000, C530S333000, C530S333000, C530S333000

Reexamination Certificate

active

11509963

ABSTRACT:
Methods of modulating pancreatic function by modulating MCH signaling in a β cell.

REFERENCES:
patent: 6291195 (2001-09-01), Salon et al.
patent: 6329403 (2001-12-01), Odaka et al.
patent: 7101845 (2006-09-01), Maratos-Flier et al.
Ozcan et al. “Melanocyte-concentrating hormone stimulates insulin release via MCH receptors expressed in islets.” Jun. 14-18, 2002, abstract presented at American Diabetes Association 62nd Annual Meeting and Scientific Sessions, San Franciso.
Audinot et al., “[125I]-S36057: a new and highly potent radioligand for the melanin-concentrating hormone receptor,” Br. J. Pharmacol. 133(3):371-378 (2001).
Bednarek et al., “Synthesis and Biological Evaluation in Vitro of Selective high affinity peptide antagonists of human melanin-concentrating hormone action at human melanin-concentrating hormone receptor 1,” Biochem., 41(20):6383-6390, (2002).
Boutin et al., “Melanin-concentrating hormone and its receptors: state of the art,” Can. J. Physiol. Pharmacol., 80(5):388-395, (2002).
Lebl et al., “Melanin concentrating hormone analogues: contraction of the cyclic structure. 1. Agonist activity,” J. Med. Chem., 31(5):949-54, (1998).
Lebl et al., “Melanin concentrating hormone analogues: contraction of the cyclic structure. II. Antagonist activity,” Life Sci., 44(7):451-457, (1989).
Ludwig et al., “Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance,” J. Clin. Invest., 107(3):379-386 (2001).
Ludwig et al., “Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus,” Am. J. Physiol. 274 (Endocrinol. Metab. 37):E627-E633, (1998).
MacDonald et al., “Molecular characterization of the melanin-concentrating hormone/receptor complex: identification of critical residues involved in binding and activation,” Mol. Pharmacol., 58(1):217-225 (2000).
Matsunaga et al., “Melanin concentrating hormone (MCH): structure-function aspects of its melanocyte stimulating hormone-like (MSH-like) activity.” Peptides, 10(4):773-8, (1989).
Maulon-Feraille et al., “Appetite-boosting property of pro-melanin-concentrating hormone(131-165) (neuropeptide-glutamic acid-isoleucine) is associated with proteolytic resistance.” J. Pharmacol. Exp. Ther. 302(2):766-773, (2002).
Ozcan et al., “Melanocyte-concentrating hormone stimulates insulin release via MCH receptors expressed in islets,” Jun. 14-18, 2002, abstract presented at American Diabetes Association 62nd Annual Meeting and Scientific Sessions, San Francisco.
Rossi et al., “Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight,” Endocrinology, 138(1):351-355, (1997).
Tritos et al., “Characterization of expression of hypothalamic appetite-regulating peptides in obese hyperleptinemic brown adipose tissue-deficient (uncoupling protein-promoter-driven diphtheria toxin A) mice,” Endocrinology, 139(11):4634-4641, (1998).
Vitale et al., “Conformational features of human melanin-concentrating hormone: an NMR and computational analysis,” Chembiochem., 4(1):73-81 (2003).

Affiliated with

Also associated with

Rating

Methods of modulating β cell function does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of modulating β cell function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of modulating β cell function will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3829950